{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-12T18:32:50.161618+00:00","company":{"ticker":"SEPN","cik":1984086,"company_name":"Septerna, Inc."},"pagination":{"limit":100,"returned":5,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"earnings_release","fact_key":"c9a99276807c6aad1976162a3f5bbf37d9476bc5","cik":1984086,"ticker":"SEPN","company_name":"Septerna, Inc.","filed_at":"2026-05-11T20:05:14+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$8.6 million","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-11","result_type":"reported_results","revenue_text":"$26.5 million"},"claim":"Septerna, Inc. reported first quarter ended March 31, 2026 results: revenue $26.5 million, net income $8.6 million.","evidence_excerpt":"$522.1 million as of March 31, 2026. Septerna expects its existing cash runway to fund operations at least into 2029. o Revenue: Revenue from the Novo Nordisk collaboration was $26.5 million for the quarter ended March 31, 2026, compared to $0.2 million from Vertex for the quarter ended March 31, 2025. Revenue for the quarter ended March 31, 2026 included the","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001193125-26-216723","anchor_url":"https://secwatch.observer/filing/0001193125-26-216723#claim-c9a99276807c6aad1976162a3f5bbf37d9476bc5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1984086/000119312526216723/0001193125-26-216723-index.htm"},{"fact_type":"earnings_release","fact_key":"9573f0a7f5ff929eb4bf8120d356bb84428637cb","cik":1984086,"ticker":"SEPN","company_name":"Septerna, Inc.","filed_at":"2026-03-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss was $10.7 million for the fourth quarter of 2025 and $48.9 million for the full year ended December 31, 2025","period_text":"the fourth quarter and full year ended December 31, 2025","report_date":"2026-03-09","result_type":"reported_results","revenue_text":"$24.1 million for the fourth quarter of 2025 and $46.0 million for the full year ended December 31, 2025"},"claim":"Septerna, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $24.1 million for the fourth quarter of 2025 and $46.0 million for the full year ended December 31, 2025, net income Net loss was $10.7 million for the fourth quarter of 2025 and $48.9 million for the full year ended December 31, 2025.","evidence_excerpt":"On March 9, 2026, Septerna, Inc. (the “Company”) announced its financial results and business highlights for the fourth quarter and year ended December 31, 2025.","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001193125-26-098489","anchor_url":"https://secwatch.observer/filing/0001193125-26-098489#claim-9573f0a7f5ff929eb4bf8120d356bb84428637cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1984086/000119312526098489/0001193125-26-098489-index.htm"},{"fact_type":"executive_change","fact_key":"26cfecff1d","cik":1984086,"ticker":"SEPN","company_name":"Septerna, Inc.","filed_at":"2025-01-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-06","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Gil M. Labrucherie was appointed as Chief Financial Officer at Septerna, Inc..","evidence_excerpt":"On December 23, 2024, the Board of Directors (the “Board”) of Septerna, Inc. (the “Company”) appointed Gil M. Labrucherie as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, in each case, effective as of January 6, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-25-001834","anchor_url":"https://secwatch.observer/filing/0001193125-25-001834#claim-26cfecff1d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1984086/000119312525001834/0001193125-25-001834-index.htm"},{"fact_type":"governance_change","fact_key":"94062989ec0b717ba70a01fd9b06fec5cddac734","cik":1984086,"ticker":"SEPN","company_name":"Septerna, Inc.","filed_at":"2024-10-28T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2024-10-24","item_codes_triggered":["5.03"],"summary_text":"Amended and restated bylaws to eliminate stockholder ability to act by written consent and call special meetings, establish advance notice procedure for stockholder proposals, and conform to amended certificate."},"claim":"Septerna, Inc.: Amended and restated bylaws to eliminate stockholder ability to act by written consent and call special meetings, establish advance notice procedure for stockholder proposals, and conform to amended certificate (effective 2024-10-24).","evidence_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Board and the Company’s stockholders, became effective as of the effectiveness of the Registration Statement on October 24, 2024. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) eliminate the ability of the Company’s stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders; (ii) establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our Board; and (iii) conform to the amended provisions of the Amended and Restated Certificate.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-245578","anchor_url":"https://secwatch.observer/filing/0001193125-24-245578#claim-94062989ec0b717ba70a01fd9b06fec5cddac734","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1984086/000119312524245578/0001193125-24-245578-index.htm"},{"fact_type":"governance_change","fact_key":"1e41c10a96da4102e2d9ed310be21ebe06df6df8","cik":1984086,"ticker":"SEPN","company_name":"Septerna, Inc.","filed_at":"2024-10-28T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-10-28","item_codes_triggered":["5.03"],"summary_text":"Amended and restated certificate of incorporation to authorize 500,000,000 shares of common stock, eliminate references to existing series of preferred stock, and authorize 10,000,000 shares of undesignated preferred stock."},"claim":"Septerna, Inc.: Amended and restated certificate of incorporation to authorize 500,000,000 shares of common stock, eliminate references to existing series of preferred stock, and authorize 10,000,000 shares of undesignated preferred stock (effective 2024-10-28).","evidence_excerpt":"The Amended and Restated Certificate amends and restates the Company’s existing amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 500,000,000 shares of common stock; (ii) eliminate all references to the previously-existing series of preferred stock; and (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Board in one or more series.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-245578","anchor_url":"https://secwatch.observer/filing/0001193125-24-245578#claim-1e41c10a96da4102e2d9ed310be21ebe06df6df8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1984086/000119312524245578/0001193125-24-245578-index.htm"}]}